Recall of ACCESS SYSTEM - INTRINSIC FACTOR AB

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by BECKMAN COULTER CANADA L.P..

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    70728
  • Event Risk Class
    III
  • Event Initiated Date
    2012-04-26
  • Event Country
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    Beckman coulter is making changes to the access intrinsic factor ab instructions for use regarding the concentration of vitamin b12 to the "limitations of the procedure" and "analytical specificiety/interferences".

Device

  • Model / Serial
    Model Catalog: 387992 (Lot serial: N/A)
  • Product Description
    ACCESS INTRINSIC FACTOR AB (FOR ACCESS IMMUNOASSAY SYSTEM)
  • Manufacturer

Manufacturer